Alivus Life Sciences Ltd.
ALIVUS Share PricePharmaceuticals & Drugs
₹872.05
-2 (-0.2%)
As on December 4, 2025
Exchange Scrips: BSE543322NSEALIVUSISININE03Q201024
Market Cap ₹ 10,733 Cr
P/E Ratio 22
Dividend Yield 0.29 %
Performance
Market performance
Open875.1
High887.2
Volumes10,36,792
Prev872.05
Low865
As on2025-12-04
Historical performance
1 Year High1,251
3 Year High1,335.1
5 Year High1,335.1
1 Year Low850
3 Year Low370
5 Year Low370
Fundamentals
Company Valuation
Market Cap (₹Cr)
10,733
Face Value (₹)
2
P/E Ratio
22
Dividend Yield
0.29 %
Investment Returns
1 Year
-20.4%
3 Years
101.6%
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 887.1 | Bearish |
| 10-DMA | 892.66 | Bearish |
| 20-DMA | 904.09 | Bearish |
| 50-DMA | 919.82 | Bearish |
| 100-DMA | 950.2 | Bearish |
| 200-DMA | 995.2 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 1 | 1 | 1 | 1 | 1 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 1 | 1 | 1 | 1 | 1 |
| Public Investors | 135642 | 138499 | 141976 | 146839 | 143959 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 22.0.
- 3Y Stock Price CAGR of the stock is 25.9.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹7172 Million.
- The company generated revenue of ₹23869 Million in the previous financial year.
Alivus Life Sciences Ltd.
872.05-2 (-0.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 811096.1
No. of Shares: 930 (Approx)
Performance:-18.9%
P/L: ₹-188903.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
